JPS6076562A - 抗血栓性樹脂組成物 - Google Patents
抗血栓性樹脂組成物Info
- Publication number
- JPS6076562A JPS6076562A JP58185599A JP18559983A JPS6076562A JP S6076562 A JPS6076562 A JP S6076562A JP 58185599 A JP58185599 A JP 58185599A JP 18559983 A JP18559983 A JP 18559983A JP S6076562 A JPS6076562 A JP S6076562A
- Authority
- JP
- Japan
- Prior art keywords
- resin
- anticoagulant
- solution
- water
- antithrombotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003146 anticoagulant agent Substances 0.000 title claims abstract description 35
- 230000002785 anti-thrombosis Effects 0.000 title claims abstract description 22
- 239000011342 resin composition Substances 0.000 title claims abstract description 6
- 229920005989 resin Polymers 0.000 claims abstract description 40
- 239000011347 resin Substances 0.000 claims abstract description 40
- 229940127219 anticoagulant drug Drugs 0.000 claims abstract description 31
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 8
- 238000009835 boiling Methods 0.000 claims abstract description 6
- 239000002245 particle Substances 0.000 claims abstract description 6
- 238000002844 melting Methods 0.000 claims abstract 2
- 230000008018 melting Effects 0.000 claims abstract 2
- 229920000642 polymer Polymers 0.000 abstract description 18
- 239000000203 mixture Substances 0.000 abstract description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 10
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract description 9
- 229960002897 heparin Drugs 0.000 abstract description 9
- 229920000669 heparin Polymers 0.000 abstract description 9
- 239000000377 silicon dioxide Substances 0.000 abstract description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 4
- 150000005846 sugar alcohols Polymers 0.000 abstract description 4
- 238000013508 migration Methods 0.000 abstract description 3
- 230000005012 migration Effects 0.000 abstract description 3
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 abstract description 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 abstract description 2
- 150000003839 salts Chemical class 0.000 abstract description 2
- 229960005356 urokinase Drugs 0.000 abstract description 2
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000004584 polyacrylic acid Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 238000000034 method Methods 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 8
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 229920003002 synthetic resin Polymers 0.000 description 6
- 239000000057 synthetic resin Substances 0.000 description 6
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 5
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 5
- 239000005977 Ethylene Substances 0.000 description 5
- OHJKXVLJWUPWQG-PNRHKHKDSA-N Heparinsodiumsalt Chemical compound O[C@@H]1[C@@H](NS(O)(=O)=O)[C@@H](O)O[C@H](COS(O)(=O)=O)[C@H]1O[C@H]1[C@H](OS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H](C(O)=O)O1 OHJKXVLJWUPWQG-PNRHKHKDSA-N 0.000 description 5
- 239000002861 polymer material Substances 0.000 description 5
- 229920002689 polyvinyl acetate Polymers 0.000 description 4
- 239000011118 polyvinyl acetate Substances 0.000 description 4
- 239000004711 α-olefin Substances 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 238000004898 kneading Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- HEAFLBOWLRRIHV-UHFFFAOYSA-N [Na].[P] Chemical compound [Na].[P] HEAFLBOWLRRIHV-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000011978 dissolution method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 229920001038 ethylene copolymer Polymers 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/062—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
- A61L33/0041—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate characterised by the choice of an antithrombatic agent other than heparin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0047—Enzymes, e.g. urokinase, streptokinase
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L101/00—Compositions of unspecified macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- External Artificial Organs (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58185599A JPS6076562A (ja) | 1983-10-03 | 1983-10-03 | 抗血栓性樹脂組成物 |
| EP84306745A EP0136916B1 (en) | 1983-10-03 | 1984-10-03 | Anthithrombic resin composition |
| DE8484306745T DE3485364D1 (de) | 1983-10-03 | 1984-10-03 | Antithrombogene harzmischung. |
| US06/904,833 US4822615A (en) | 1983-10-03 | 1986-09-09 | Antithrombic resin composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58185599A JPS6076562A (ja) | 1983-10-03 | 1983-10-03 | 抗血栓性樹脂組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6076562A true JPS6076562A (ja) | 1985-05-01 |
| JPS6219872B2 JPS6219872B2 (enExample) | 1987-05-01 |
Family
ID=16173615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58185599A Granted JPS6076562A (ja) | 1983-10-03 | 1983-10-03 | 抗血栓性樹脂組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4822615A (enExample) |
| EP (1) | EP0136916B1 (enExample) |
| JP (1) | JPS6076562A (enExample) |
| DE (1) | DE3485364D1 (enExample) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6245537A (ja) * | 1985-08-23 | 1987-02-27 | Sumitomo Electric Ind Ltd | 医用樹脂組成物及びその製造方法 |
| JPH03297469A (ja) * | 1990-04-17 | 1991-12-27 | Sumitomo Bakelite Co Ltd | 抗血栓性材料及びその製造方法 |
| US5097317A (en) * | 1989-09-08 | 1992-03-17 | Mitsubishi Denki Kabushiki Kaisha | Resin-sealed semiconductor device |
| JPH0678990A (ja) * | 1990-08-06 | 1994-03-22 | Becton Dickinson & Co | 基材表面を凝塊形成防止性及び／或いは抗感染性にする方法 |
| WO1995031228A1 (en) * | 1994-05-17 | 1995-11-23 | Otsuka Pharmaceutical Factory, Inc. | Method of inhibiting blood coagulation during extracorporeal blood circulation and device for releasing antithrombotic drug used therein |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987006846A1 (en) * | 1986-05-08 | 1987-11-19 | Meir Lichtenstein | Improvements in or relating to bio-compatible non-thrombogenic surfaces |
| DE3639561A1 (de) * | 1986-11-20 | 1988-06-01 | Baumann Hanno | Verfahren zur herstellung von nicht-thrombogenen substraten |
| DE3777128D1 (de) * | 1986-12-25 | 1992-04-09 | Sumitomo Electric Industries | Verfahren zur herstellung eines medizinischen vinylchloridharzmaterials. |
| DE3874440T2 (de) * | 1987-07-14 | 1993-01-28 | Sankyo Co | Zusammensetzung zur herstellung von antithrombotischen medizinischen erzeugnissen. |
| CH683673A5 (de) * | 1991-10-01 | 1994-04-29 | Otsuka Pharma Co Ltd | Antithromboseharz, Antithromboseröhrchen, Antithrombosefilm und Antithromboseüberzug. |
| WO1993011751A1 (en) * | 1991-12-18 | 1993-06-24 | Scimed Life Systems, Inc. | Lubricous polymer network |
| DE4221665C1 (enExample) * | 1992-07-02 | 1993-08-12 | Rehau Ag + Co, 8673 Rehau, De | |
| US5380299A (en) * | 1993-08-30 | 1995-01-10 | Med Institute, Inc. | Thrombolytic treated intravascular medical device |
| AU1504895A (en) | 1994-07-11 | 1996-01-25 | Meadox Medicals, Inc. | Expanded PTFE implantable prosthesis with improved blood and tissue compatibility and superior potency |
| US6165158A (en) | 1998-10-14 | 2000-12-26 | Advanced Cardiovascular Systems, Inc. | Lubricious catheter shaft |
| KR102025892B1 (ko) * | 2016-02-17 | 2019-09-26 | 주식회사 엘지화학 | 내고화성이 향상된 고흡수성 수지의 제조 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3625745A (en) * | 1970-03-18 | 1971-12-07 | Gen Electric | Antithrombogenic article and process |
| US3673612A (en) * | 1970-08-28 | 1972-07-04 | Massachusetts Inst Technology | Non-thrombogenic materials and methods for their preparation |
| FR2142277A5 (en) * | 1971-06-18 | 1973-01-26 | Gen Electric | Antithrombogenic surfaces |
| JPS5515222B2 (enExample) * | 1972-08-18 | 1980-04-22 | ||
| IT1085524B (it) * | 1977-03-22 | 1985-05-28 | Snam Progetti | Materiali e fibre porose biocompatibili in grado di inglobare sostanze di interesse biologico e metodi per il loro ottenimento |
| US4329383A (en) * | 1979-07-24 | 1982-05-11 | Nippon Zeon Co., Ltd. | Non-thrombogenic material comprising substrate which has been reacted with heparin |
| US4500676A (en) * | 1983-12-15 | 1985-02-19 | Biomatrix, Inc. | Hyaluronate modified polymeric articles |
-
1983
- 1983-10-03 JP JP58185599A patent/JPS6076562A/ja active Granted
-
1984
- 1984-10-03 EP EP84306745A patent/EP0136916B1/en not_active Expired
- 1984-10-03 DE DE8484306745T patent/DE3485364D1/de not_active Expired - Lifetime
-
1986
- 1986-09-09 US US06/904,833 patent/US4822615A/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6245537A (ja) * | 1985-08-23 | 1987-02-27 | Sumitomo Electric Ind Ltd | 医用樹脂組成物及びその製造方法 |
| US5097317A (en) * | 1989-09-08 | 1992-03-17 | Mitsubishi Denki Kabushiki Kaisha | Resin-sealed semiconductor device |
| JPH03297469A (ja) * | 1990-04-17 | 1991-12-27 | Sumitomo Bakelite Co Ltd | 抗血栓性材料及びその製造方法 |
| JPH0678990A (ja) * | 1990-08-06 | 1994-03-22 | Becton Dickinson & Co | 基材表面を凝塊形成防止性及び／或いは抗感染性にする方法 |
| WO1995031228A1 (en) * | 1994-05-17 | 1995-11-23 | Otsuka Pharmaceutical Factory, Inc. | Method of inhibiting blood coagulation during extracorporeal blood circulation and device for releasing antithrombotic drug used therein |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0136916A2 (en) | 1985-04-10 |
| JPS6219872B2 (enExample) | 1987-05-01 |
| EP0136916B1 (en) | 1991-12-18 |
| US4822615A (en) | 1989-04-18 |
| DE3485364D1 (de) | 1992-01-30 |
| EP0136916A3 (en) | 1987-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6076562A (ja) | 抗血栓性樹脂組成物 | |
| CN1070704C (zh) | 钙改性氧化纤维素止血剂 | |
| US3826678A (en) | Method for preparation of biocompatible and biofunctional materials and product thereof | |
| US6497902B1 (en) | Ionically crosslinked hydrogels with adjustable gelation time | |
| EP0344118A2 (en) | New polymer composition | |
| CN1610724A (zh) | 作为交联的聚乙烯醇水凝胶结构的增强的、层状的、浸渍的和复合状的材料 | |
| US3914341A (en) | Hydrogel and method of manufacturing the same | |
| JPH07502563A (ja) | 親水性表面を有する生物材料 | |
| JP3907625B2 (ja) | 高分子ハイドロゲル | |
| Bisen et al. | Reverse indentation size effects in gamma irradiated blood compatible blend films of chitosan-poly (vinyl alcohol) for possible medical applications | |
| JPH0522737B2 (enExample) | ||
| US4869909A (en) | Process for producing a medical vinyl chloride resin material | |
| CN1254734A (zh) | 基于聚烯烃的多孔膜 | |
| JP3589842B2 (ja) | 前加硫天然ゴムラテックスと水溶性ポリマーの混合物からの成形方法及びその成形品 | |
| JPS62227932A (ja) | 透湿性放香フイルム | |
| JP2965561B1 (ja) | 絹タンパク質含有ハイドロゲル組成物 | |
| JP3378046B2 (ja) | 熱可塑性重合体組成物 | |
| JPH09262279A (ja) | 粘着性ハイドロゲルの製造方法 | |
| JPS6121159A (ja) | 芳香性熱可塑性樹脂組成物 | |
| JPS6346778B2 (enExample) | ||
| He et al. | A Dual‐Crosslinked Collagen/Oxidized Cellulose Composite Sponge Synergistically Constructed via Polyelectrolyte Complexation for Efficient Emergency Hemostasis | |
| EP3717028A1 (en) | Wound-treating absorbent | |
| JPH0366904B2 (enExample) | ||
| JPH07284528A (ja) | 医療材料用合成高分子 | |
| EP0213918A2 (en) | A process for producing a medical resin composition. |